These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9388049)

  • 21. Increased resistance to ischaemic injury in the isolated perfused atherosclerotic heart of the cholesterol-fed rabbit.
    Le Grand B; Vié B; Fauré P; Degryse AD; Mouillard P; John GW
    Cardiovasc Res; 1995 Nov; 30(5):689-96. PubMed ID: 8595614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reviparin: a review of its efficacy in the prevention and treatment of venous thromboembolism.
    Wellington K; McClellan K; Jarvis B
    Drugs; 2001; 61(8):1185-209. PubMed ID: 11465877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High and low heparin dose with heparin-coated cardiopulmonary bypass: activation of complement and granulocytes.
    Ovrum E; Mollnes TE; Fosse E; Holen EA; Tangen G; Ringdal MA; Videm V
    Ann Thorac Surg; 1995 Dec; 60(6):1755-61. PubMed ID: 8787476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury.
    Crawford MH; Grover FL; Kolb WP; McMahan CA; O'Rourke RA; McManus LM; Pinckard RN
    Circulation; 1988 Dec; 78(6):1449-58. PubMed ID: 3191598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, Early Administration of Reviparin in a Double-Blind Unfractionated Heparin and Placebo-Controlled Evaluation.
    Karsch KR; Preisack MB; Baildon R; Eschenfelder V; Foley D; Garcia EJ; Kaltenbach M; Meisner C; Selbmann HK; Serruys PW; Shiu MF; Sujatta M; Bonan R
    J Am Coll Cardiol; 1996 Nov; 28(6):1437-43. PubMed ID: 8917255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute cocaine exposure up-regulates complement expression in rabbit heart.
    Tanhehco EJ; Yasojima K; McGeer PL; Lucchesi BR
    J Pharmacol Exp Ther; 2000 Jan; 292(1):201-8. PubMed ID: 10604949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serine protease inhibitor nafamostat given before reperfusion reduces inflammatory myocardial injury by complement and neutrophil inhibition.
    Schwertz H; Carter JM; Russ M; Schubert S; Schlitt A; Buerke U; Schmidt M; Hillen H; Werdan K; Buerke M
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):151-60. PubMed ID: 18670364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sublytic complement attack reduces infarct size in rabbit isolated hearts: evidence for C5a-mediated cardioprotection.
    Tanhehco EJ; Lee H; Lucchesi BR
    Immunopharmacology; 2000 Sep; 49(3):391-9. PubMed ID: 10996036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced fibrin deposition and intravascular thrombosis in hDAF transgenic pig hearts perfused with tirofiban.
    Brandl U; Jöckle H; Erhardt M; Michel S; Burdorf L; Brenner P; Bittmann I; Rössle M; Mordstein V; Hammer C; Thein E; Reichart B; Schmoeckel M
    Transplantation; 2007 Dec; 84(12):1667-76. PubMed ID: 18165780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of the mechanisms of anti-complement activity in Ixodes ricinus ticks.
    Lawrie CH; Sim RB; Nuttall PA
    Mol Immunol; 2005 Jan; 42(1):31-8. PubMed ID: 15488941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The complement regulators C1 inhibitor and soluble complement receptor 1 attenuate acute lung injury in rabbits.
    Heller A; Kunz M; Samakas A; Haase M; Kirschfink M; Koch T
    Shock; 2000; 13(4):285-90. PubMed ID: 10774617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of propofol and thiopental on coronary blood flow and myocardial performance in an isolated rabbit heart.
    Mouren S; Baron JF; Albo C; Szekely B; Arthaud M; Viars P
    Anesthesiology; 1994 Mar; 80(3):634-41. PubMed ID: 8141459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of chronic renal allograft rejection in rats with a low-molecular-weight heparin (reviparin).
    Braun C; Schultz M; Fang L; Schaub M; Back WE; Herr D; Laux V; Rohmeiss P; Schnuelle P; van der Woude FJ
    Transplantation; 2001 Jul; 72(2):209-15. PubMed ID: 11477340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of the terminal complement-complex on reperfusion injury, no-reflow and arrhythmias: a comparison between C6-competent and C6-deficient rabbits.
    Ito W; Schäfer HJ; Bhakdi S; Klask R; Hansen S; Schaarschmidt S; Schofer J; Hugo F; Hamdoch T; Mathey D
    Cardiovasc Res; 1996 Aug; 32(2):294-305. PubMed ID: 8796116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Free radicals upregulate complement expression in rabbit isolated heart.
    Tanhehco EJ; Yasojima K; McGeer PL; Washington RA; Lucchesi BR
    Am J Physiol Heart Circ Physiol; 2000 Jul; 279(1):H195-201. PubMed ID: 10899056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disodium Disuccinate Astaxanthin (Cardax) attenuates complement activation and reduces myocardial injury following ischemia/reperfusion.
    Lauver DA; Lockwood SF; Lucchesi BR
    J Pharmacol Exp Ther; 2005 Aug; 314(2):686-92. PubMed ID: 15872041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation.
    Kroshus TJ; Rollins SA; Dalmasso AP; Elliott EA; Matis LA; Squinto SP; Bolman RM
    Transplantation; 1995 Dec; 60(11):1194-202. PubMed ID: 8525509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs.
    Amsterdam EA; Stahl GL; Pan HL; Rendig SV; Fletcher MP; Longhurst JC
    Am J Physiol; 1995 Jan; 268(1 Pt 2):H448-57. PubMed ID: 7840295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple genetically modified GTKO/hCD46/HLA-E/hβ2-mg porcine hearts are protected from complement activation and natural killer cell infiltration during ex vivo perfusion with human blood.
    Abicht JM; Sfriso R; Reichart B; Längin M; Gahle K; Puga Yung GL; Seebach JD; Rieben R; Ayares D; Wolf E; Klymiuk N; Baehr A; Kind A; Mayr T; Bauer A
    Xenotransplantation; 2018 Sep; 25(5):e12390. PubMed ID: 29536572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo generation of C4d, Bb, iC3b, and SC5b-9 after OKT3 administration in kidney and lung transplant recipients.
    Vallhonrat H; Williams WW; Cosimi AB; Tolkoff-Rubin N; Ginns LC; Wain JC; Preffer F; Olszak I; Wee S; Delmonico FL; Pascual M
    Transplantation; 1999 Jan; 67(2):253-8. PubMed ID: 10075589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.